Cite
HARVARD Citation
White, B. et al. (n.d.). P-230 YI Vedolizumab Resulted in Resolution of Anti-Tumor Necrosis Factor Psoriasis and Sustained Clinical and Endoscopic Remission of Crohn's Colitis. Inflammatory bowel diseases. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
White, B. et al. (n.d.). P-230 YI Vedolizumab Resulted in Resolution of Anti-Tumor Necrosis Factor Psoriasis and Sustained Clinical and Endoscopic Remission of Crohn's Colitis. Inflammatory bowel diseases. p. . [Online].